VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults
Clinical trial NCT02408913 · COMPLETED
Trial details
- NCT number
- NCT02408913
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-26
- Primary completion
- 2017-04-06
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.